US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco KBW Premium Yield Equity REIT ETF

18.40

+0.05900.32%

Post-market: 18.11-0.2871-1.56%19:30 EDT

Volume:386.39K

Turnover:7.09M

Market Cap:316.83M

PE:- -

High:18.41

Open:18.33

Low:18.28

Close:18.34

52wk High:19.35

52wk Low:14.82

Shares:17.22M

Float Shares:17.22M

Volume Ratio:2.17

T/O Rate:2.24%

Dividend:1.49

Dividend Rate:8.07%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Morgan Stanley Adjusts PT on Park Hotels & Resorts to $11 From $10.50, Maintains Equalweight Rating

MT Newswires Live

Innovative Industrial Properties (IIPR) Stock May Be 49% Undervalued Despite 52 Week High

Simply Wall St.

Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins

JLL Reports Sustained Recovery in Shanghai Commercial Property Leasing and Increased Investment Activity

Gladstone Commercial initiated with a Market Perform at Huntington

Gladstone Commercial Publishes Financial Calendar Update

Gladstone Commercial Declares USD 0.10 Monthly Common Distribution for July-september 2026

Three Landmark Projects Simultaneously Break Ground, Signaling Recovery Momentum in Manhattan Commercial Real Estate

LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer’s Disease Presented at the Alzheimer’s Association International Conference® (AAIC®) 2026

Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress

Peapack Private Appoints Paul Kotronis as Senior Managing Director, Commercial Real Estate

JLL: Beijing Office Market Enters Phase of Systemic Restructuring

FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months

MERLIN Properties Sets Date for H1 2026 Results and Investor Call

U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease

Makkah Construction Signs Contract with Roots Innovative Industrial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/KBWY/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KBWY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KBWY\",,,,,undefined,":{"symbol":"KBWY","market":"US","secType":"STK","nameCN":"Invesco KBW Premium Yield Equity REIT ETF","latestPrice":18.399,"timestamp":1787688000000,"preClose":18.34,"halted":0,"volume":386387,"hourTrading":{"tag":"盘后","latestPrice":18.1119,"preClose":18.399,"latestTime":"19:30 EDT","volume":530,"amount":9607.0268,"timestamp":1787700600860,"change":-0.2871,"changeRate":-0.015604,"amplitude":0.015658},"delay":0,"changeRate":0.003217011995638007,"floatShares":17220000,"shares":17220000,"eps":0,"marketStatus":"Not Yet Opened","change":0.059,"latestTime":"08-25 16:00:00 EDT","open":18.33,"high":18.41,"low":18.28,"amount":7091241.603804001,"amplitude":0.007088,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":18.34,"sharesOutstanding":16420000,"nav":18.32248,"aum":316429229.6,"dividendRate":0.080722,"bidAskSpread":0.000588,"postHourTrading":{"tag":"盘后","latestPrice":18.1119,"preClose":18.399,"latestTime":"19:30 EDT","volume":530,"amount":9607.0268,"timestamp":1787700600860,"change":-0.2871,"changeRate":-0.015604,"amplitude":0.015658},"volumeRatio":2.165033,"impliedVol":0.0402,"impliedVolPercentile":0.3466},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KBWY\",,,,,undefined,":{"symbol":"KBWY","floatShares":17220000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.165033,"shares":17220000,"dividePrice":1.4852,"high":18.41,"amplitude":0.007088,"preClose":18.34,"low":18.28,"week52Low":14.815,"pbRate":"--","week52High":19.35,"institutionHeld":0,"latestPrice":18.399,"eps":0,"divideRate":0.080722,"volume":386387,"delay":0,"ttmEps":0,"open":18.33,"prevYearClose":15.4324,"prevWeekClose":18.28,"prevMonthClose":18.39,"prevQuarterClose":18.57,"fiveDayClose":17.89,"twentyDayClose":18.85,"sixtyDayClose":17.4718},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KBWY\",params:#limit:5,,,undefined,":[{"date":"2026-08-24","symbol":"KBWY","amount":0.1199,"announcedDate":"2026-08-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-24","defaultRemindTime":1787578200000,"name":"Invesco KBW Premium Yield Equity REIT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-28","payableDate":"2026-08-24","currency":"USD","dateTimestamp":1787544000000,"payDate":"2026-08-28"},{"date":"2026-07-20","symbol":"KBWY","amount":0.11998,"announcedDate":"2026-07-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-20","defaultRemindTime":1784554200000,"name":"Invesco KBW Premium Yield Equity REIT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-24","payableDate":"2026-07-20","currency":"USD","dateTimestamp":1784520000000,"payDate":"2026-07-24"},{"date":"2026-06-22","symbol":"KBWY","amount":0.12001,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco KBW Premium Yield Equity REIT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-05-18","symbol":"KBWY","amount":0.12252,"announcedDate":"2026-05-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-18","defaultRemindTime":1779111000000,"name":"Invesco KBW Premium Yield Equity REIT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-22","payableDate":"2026-05-18","currency":"USD","dateTimestamp":1779076800000,"payDate":"2026-05-22"},{"date":"2026-04-20","symbol":"KBWY","amount":0.12502,"announcedDate":"2026-04-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-20","defaultRemindTime":1776691800000,"name":"Invesco KBW Premium Yield Equity REIT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-24","payableDate":"2026-04-20","currency":"USD","dateTimestamp":1776657600000,"payDate":"2026-04-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KBWY\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-15","recordDate":"2016-09-19","paymentDate":"2016-09-30","value":0.22247,"currency":"USD"},{"executeDate":"2016-10-14","recordDate":"2016-10-18","paymentDate":"2016-10-31","value":0.27757,"currency":"USD"},{"executeDate":"2016-11-15","recordDate":"2016-11-17","paymentDate":"2016-11-30","value":0.22626,"currency":"USD"},{"executeDate":"2016-12-15","recordDate":"2016-12-19","paymentDate":"2016-12-30","value":0.22488,"currency":"USD"},{"executeDate":"2017-01-13","recordDate":"2017-01-18","paymentDate":"2017-01-31","value":0.21316,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KBWY\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KBWY\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2652401908","title":"Morgan Stanley Adjusts PT on Park Hotels & Resorts to $11 From $10.50, Maintains Equalweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2652401908","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652401908?lang=en_us&edition=fundamental","pubTime":"2026-07-17 17:39","pubTimestamp":1784281178,"startTime":"0","endTime":"0","summary":"Park Hotels & Resorts (PK) has an average rating of hold and mean price target of $14.13, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PK","KBWY","BK4218","BK4181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652797804","title":"Innovative Industrial Properties (IIPR) Stock May Be 49% Undervalued Despite 52 Week High","url":"https://stock-news.laohu8.com/highlight/detail?id=2652797804","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652797804?lang=en_us&edition=fundamental","pubTime":"2026-07-17 10:35","pubTimestamp":1784255725,"startTime":"0","endTime":"0","summary":"Innovative Industrial Properties stock is trading near a 52 week high while both a Discounted Cash Flow (DCF) intrinsic value estimate and earnings based multiples point to the shares screening as undervalued. This sits in tension with a 5 year return that has declined 52.1%.\n\nOver the past 5 years, Innovative Industrial Properties has delivered a 52.1% decline, so the recent strength comes against a weak longer term share price record.\nRecent news around fresh senior and exchangeable note...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551732-choice2-main-header/1585187231071","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551732-choice2-main-header/1585187231071"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-iipr/innovative-industrial-properties/news/innovative-industrial-properties-iipr-stock-may-be-49-underv","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-iipr/innovative-industrial-properties/news/innovative-industrial-properties-iipr-stock-may-be-49-underv","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FEBU","GXDW","BK4588","DCF","IIPR","SPHQ","DECU","VGFPF","BK4171","VOTE","KBWY","BK4224","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651441085","title":"Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins","url":"https://stock-news.laohu8.com/highlight/detail?id=2651441085","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651441085?lang=en_us&edition=fundamental","pubTime":"2026-07-16 20:00","pubTimestamp":1784203200,"startTime":"0","endTime":"0","summary":"One trial, SIGMA, will evaluate Grifols’ intravenous immunoglobulin (Ig) GAMUNEX-C (immune globulin injection [human], 10% caprylate chromatography purified) plus standard medical treatment in patient","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/16/3328383/0/en/Grifols-Doses-First-Patients-in-Two-Phase-3-Trials-to-Expand-Indications-of-its-Flagship-Immunoglobulins.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PK","BK4006","BK4199","KBWY","BK4181","PID","BK4218","ITP","AMS","BK4196","GRFS","SID","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121366332","title":"JLL Reports Sustained Recovery in Shanghai Commercial Property Leasing and Increased Investment Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=1121366332","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121366332?lang=en_us&edition=fundamental","pubTime":"2026-07-15 12:40","pubTimestamp":1784090459,"startTime":"0","endTime":"0","summary":"Shanghai's commercial real estate market demonstrated continued recovery in activity during the second quarter of 2026, with overall leasing demand and investment interest in major transactions...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4079","GRI","IYRI","BK4550","JPRE","GQRE","BK4007","KBWY","LU0128526141.USD","URE","HIPS","SRHR","BLDG","DFGR","IQRA","FPRO","RINC","HAUZ","LU0029874061.USD","RWO","ERET","SRS","SRET","PSR","IRET","BYRE","LU0054578231.USD","CSRE","DFAR","FREL","RSPR","JRE","BK4139","JLL","REAI","VGSR","AVRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651841124","title":"Gladstone Commercial initiated with a Market Perform at Huntington","url":"https://stock-news.laohu8.com/highlight/detail?id=2651841124","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651841124?lang=en_us&edition=fundamental","pubTime":"2026-07-15 05:50","pubTimestamp":1784065827,"startTime":"0","endTime":"0","summary":"Huntington initiated coverage of Gladstone Commercial (GOOD) with a Market Perform rating and $13 price target Published first on TheFly – the ulti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gladstone-commercial-initiated-with-a-market-perform-at-huntington-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gladstone-commercial-initiated-with-a-market-perform-at-huntington-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4160","KBWY","GOOD","GOODM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651648996","title":"Gladstone Commercial Publishes Financial Calendar Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2651648996","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651648996?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:16","pubTimestamp":1784060211,"startTime":"0","endTime":"0","summary":"Gladstone Commercial publishes financial calendar updateGladstone Commercial schedules Q2 earnings release for Aug. 5, 2026, following the U.S. market close.Earnings conference call set for Aug. 6, 20","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL2ZRNTt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBWY","BK4160","GOOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651950489","title":"Gladstone Commercial Declares USD 0.10 Monthly Common Distribution for July-september 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651950489","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651950489?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:16","pubTimestamp":1784060171,"startTime":"0","endTime":"0","summary":"Gladstone Commercial declares USD 0.10 monthly common distribution for July-September 2026Gladstone Commercial declared monthly cash distributions for July, August, September 2026.Common stock distrib","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL4rBzNz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOOD","BK4160","KBWY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127549012","title":"Three Landmark Projects Simultaneously Break Ground, Signaling Recovery Momentum in Manhattan Commercial Real Estate","url":"https://stock-news.laohu8.com/highlight/detail?id=1127549012","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127549012?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:30","pubTimestamp":1783931444,"startTime":"0","endTime":"0","summary":"Manhattan's commercial real estate market in New York City has recently witnessed a concentrated wave of breakthroughs, with three landmark commercial projects moving into implementation. Market...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI","IRET","VGSR","SRET","FPRO","DFGR","DFAR","JRE","GQRE","RWO","BK4007","ERET","IYRI","CSRE","SRS","IQRA","HIPS","REAI","BK4550","BLDG","RSPR","KBWY","BK4139","URE","HAUZ","RINC","BYRE","AVRE","JPRE","SRHR","FREL","PSR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650374165","title":"LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer’s Disease Presented at the Alzheimer’s Association International Conference® (AAIC®) 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2650374165","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650374165?lang=en_us&edition=fundamental","pubTime":"2026-07-12 23:18","pubTimestamp":1783869480,"startTime":"0","endTime":"0","summary":"New clinical and real-world data support a subcutaneous treatment pathway from initiation through maintenance treatment, offering dosing convenience for patients and care partnersTOKYO and CAMBRIDGE, ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/12/3325847/0/en/LEQEMBI-Subcutaneous-Autoinjector-Clinical-Data-Supports-Similar-Efficacy-and-Safety-to-IV-Formulation-in-Early-Alzheimer-s-Disease-Presented-at-the-Alzheimer-s-Association-Interna.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4110","BK4218","QTOC","AD","LU1169590202.USD","AAIC","BK4181","BK4132","KBWY","LU1169589451.USD","CHAT","PK","ARTY","AIPO","PD","VTHR","AGIX","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650061168","title":"Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2650061168","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650061168?lang=en_us&edition=fundamental","pubTime":"2026-07-12 18:28","pubTimestamp":1783852080,"startTime":"0","endTime":"0","summary":"HMB-002 clinical data demonstrate proof of mechanism, with dose-dependent, greater than or equal to 2.4-fold peak increases in Von Willebrand Factor (VWF) and Factor VIII (FVIII), normalization of pea","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/12/3325841/0/en/Hemab-Therapeutics-Presents-New-Clinical-Data-from-HMB-002-in-Von-Willebrand-Disease-and-Introduces-HMB-003-for-Heavy-Menstrual-Bleeding-at-the-ISTH-2026-Congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IDNA","HYLG","BK4539","GDOC","MEDX","BK4139","PK","BK4181","LENZ","KBWY","BK4218"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650134278","title":"Peapack Private Appoints Paul Kotronis as Senior Managing Director, Commercial Real Estate","url":"https://stock-news.laohu8.com/highlight/detail?id=2650134278","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650134278?lang=en_us&edition=fundamental","pubTime":"2026-07-11 02:07","pubTimestamp":1783706820,"startTime":"0","endTime":"0","summary":"Senior Vice President, Commercial Real Estate, Peapack Private","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/10/3325709/0/en/Peapack-Private-Appoints-Paul-Kotronis-as-Senior-Managing-Director-Commercial-Real-Estate.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ITAN","FRI","DESK","IYRI","CRED","GRI","HIPS","HAUZ","URE","NETL","FXO","PFFR","IWN","IRET","IQRA","JPRE","BBRE","BLDG","DFAR","SRHR","FREL","BYRE","HYIN","FTXO","GQRE","KBWB","REET","GMOV","JPO","FLV","DFNL","INKM","VGSR","KBWD","JRE","DFGR","MDIV","AREA","IFGL","NURE","AVRE","ALTY","IWS","INDS","KRE","KBWY","CSRE","FPRO","ICF","GABF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166095170","title":"JLL: Beijing Office Market Enters Phase of Systemic Restructuring","url":"https://stock-news.laohu8.com/highlight/detail?id=1166095170","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166095170?lang=en_us&edition=fundamental","pubTime":"2026-07-10 18:01","pubTimestamp":1783677691,"startTime":"0","endTime":"0","summary":"Beijing's commercial real estate market is undergoing a profound structural transformation.The current state of the Beijing office market does not represent a simple cyclical adjustment but rather...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSRE","BYRE","RINC","URE","ERET","DFAR","SRS","JPRE","RSPR","HAUZ","LU0128526141.USD","LU0029874061.USD","BK4079","LU0054578231.USD","PSR","DFGR","JLL","KBWY","IYRI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649996123","title":"FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2649996123","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649996123?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:00","pubTimestamp":1783512000,"startTime":"0","endTime":"0","summary":"FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase 2 open-label INTEGUMENT-INFANT study and Phase 1 open-l","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/08/3324020/0/en/FDA-Accepts-Supplemental-New-Drug-Application-for-Arcutis-ZORYVE-roflumilast-Cream-0-05-for-the-Treatment-of-Mild-to-Moderate-Atopic-Dermatitis-in-Infants-Down-to-3-Months.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4588","PK","BK4181","KBWY","BK4218"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649982055","title":"MERLIN Properties Sets Date for H1 2026 Results and Investor Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2649982055","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649982055?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:03","pubTimestamp":1783425834,"startTime":"0","endTime":"0","summary":"MERLIN Properties SOCIMI SA ( ($ES:MRL) ) has shared an update. MERLIN Properties SOCIMI, S.A., a leading Spanish commercial real estate investment...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/merlin-properties-sets-date-for-h1-2026-results-and-investor-call?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/merlin-properties-sets-date-for-h1-2026-results-and-investor-call?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALTY","GQRE","ICF","HIPS","JRE","IYRI","FXO","BBRE","INKM","PPTY","HAUZ","NURE","KRE","NETL","DFGR","CRED","KBWY","IRET","AVRE","FTXO","AREA","FREL","KBWB","BLDG","IQRA","ITAN","DFAR","KBWD","DESK","PFI","FPRO","DFNL","CSRE","IWS","FRI","GMOV","MDIV","PFFR","FLV","PSCF","INDS","HYIN","GABF","BYRE","IFGL","JPO","REET","IWN","GRI","JPRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649984691","title":"U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984691","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649984691?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:00","pubTimestamp":1783422000,"startTime":"0","endTime":"0","summary":"FDA’s PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease CAMBRIDGE, Mass., July  07, 2026  (GLOBE NEWSW","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/07/3323022/31990/en/U-S-FDA-Grants-Priority-Review-to-Agios-sNDA-for-Mitapivat-in-Sickle-Cell-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","BK4181","KBWY","BK4585","LABU","PK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649604617","title":"Makkah Construction Signs Contract with Roots Innovative Industrial","url":"https://stock-news.laohu8.com/highlight/detail?id=2649604617","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649604617?lang=en_us&edition=fundamental","pubTime":"2026-07-07 14:34","pubTimestamp":1783406084,"startTime":"0","endTime":"0","summary":"July 7 (Reuters) - MAKKAH CONSTRUCTION AND DEVELOPMENT COMPANY <4100.SE>::*ANNOUNCES CONTRACT SIGN OFF WITH ROOTS INNOVATIVE INDUSTRIAL COMPANY*CONTRACT FOR EXECUTION OF RENOVATION WORKS FOR HOTEL AND","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nRSD6tDj6J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IIPR","BK4224","BK4171","KBWY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":6,"totalSize":116,"code":"91000000","status":"200"}]}}